Frankfurt - Delayed Quote • EUR DIAGNOS Inc. (4D4A.F) Follow 0.3060 0.0000 (0.00%) At close: August 18 at 8:07 AM GMT+2 Comparisons Indicators Technicals Corporate Events Chart Types Aggregated Types Draw Table View List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Date Close Open High Low Volume O H L C Vol AAPL Loading Chart for 4D4A.F 1D 5D 1M 3M 6M YTD 1Y 2Y 5Y All Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours Recent News: 4D4A.F View More All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations DIAGNOS to expedite application for Medical Device License to Health Canada and US FDA related to its 4 new analysis modules, and is planning ISO 27001 certification AI & Technology Hybrid Investor Conference Agenda: Presentations Now Available for Online Viewing AI & Technology Hybrid Investor Conference Presented by Water Tower Research Agenda Announced for April 10 and 11 DIAGNOS Inc. to Present at the AI & Technology Hybrid Investor Conference April 11th DIAGNOS Announces Grant of Stock Options DIAGNOS Welcomes Dr. Philippe Couillard to its Board of Directors DIAGNOS Announces Closing of Second and Final Tranche of Private Placement DIAGNOS Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS In Line DIAGNOS Welcomes Mr. Michael Braeuel to its Board of Directors DIAGNOS Announces Closing of First Tranche of Private Placement Diagnos Announces Variation in One Insider Ownership of Common Shares DIAGNOS recognized as a Top TSX Venture Exchange Company
